Asahi Kasei in $1.3bn Veloxis acquisition

28-11-2019

Rory O'Neill

Asahi Kasei in $1.3bn Veloxis acquisition

IgorGolovniov / Shutterstock.com

Japanese pharmaceutical conglomerate Asahi Kasei has announced it will acquire Danish company Veloxis Pharmaceuticals for $1.3 billion.


Asahi Kasei, Veloxis Pharmaceuticals, Envarsus XR, immunosuppressive, Woolsey Pharmaceuticals, drug licensing

LSIPR